Disclaimer: This document is an English translation of the original document in Japanese and has been prepared solely for reference purposes. In the event of any discrepancy between this English translation and the original in Japanese, the original shall prevail in all respects.
August 9, 2024 Name of listed company: SHIP HEALTHCARE HOLDINGS, INC. Shares listed on: Tokyo Stock Exchange 3360 URL https://www.shiphd.co.jp/en/ Code: (Name) Futoshi Ohashi Representative: (Title) President Contact: (Title) Executive Director (Name) Hiroshi Yokoyama Tel.: +81-6-6369-0130 Scheduled start date for dividend payments: - Supplementary briefing materials on results:   None Briefing on quarterly results: None (All figures are rounded down to the nearest million yen.) 1. Consolidated financial results for the first quarter of fiscal year ending March 31, 2025 (April 1, 2024 – June 30, 2024) (1) Consolidated operating results (cumulative total)
Note: Diluted net income per shares in Q1 FY ending March 2025 are not stated because there are no outstanding potential shares.
Note: Dividend breakdown for the end of the fiscal year ended March 31, 2024 Ordinary dividend 45.00 yen Commemorative dividend 5.00 yen 3. Forecast of consolidated financial results for the fiscal year ending March 31, 2025 (April 1, 2024 – March 31, 2025)
Notes (1) Significant changes in the scope of consolidation during consolidated cumulative quarter: Yes Newly joined    – companies (Name of company) – Out of consolidation    2 companies (Notes) (Notes) Details are in the attached document Page 9 "Changes in the scope of consolidation or of application of equity method" (2) Application of special accounting methods for preparation of quarterly consolidated financial statements None (3) Changes made in accounting policies, accounting estimates, and/or restatements: (i) Changes in accounting policies associated with changes in accounting standards, etc.: Yes (ii) Any changes in accounting policies other than those under (i) above: None (iii) Changes in accounting estimates: None (iv) Restatements: None (4) Number of shares issued and outstanding (common stocks) (i)   Number of shares issued and outstanding Q1 FY ending at the end of the period (including treasury March 2025 stock) Q1 FY ending (ii)  Number of treasury stock at the end of the March 2025 period
(iii) Average number of shares during the period (quarterly cumulative) * Review of the attached quarterly consolidated financial statements by a Certified Public Accountant or an audit firm :Yes (arbitrary) * Information on appropriate use of financial forecasts and other special notes: • The forecasts of financial results and other forward-looking statements provided herein are based on information available at the time this document was prepared, and certain assumptions considered reasonable. We don't intend to promise the achievement of them. Actual results may differ significantly from forecasts due to various factors. For assumptions underlying forecasts of financial results, notes on use of forecasts of financial results, and other related information, please refer to "Information on consolidated financial forecasts and other forward-looking statements" on page 3 of the Annexed Materials. SHIP HEALTHCARE HOLDINGS, INC. (3360): Summary of Financial Statements for First Quarter of Fiscal Year Ending March 31, 2025 ○ Index of attached materials

1. Outlook of business results
(1) Outlook Description of business results of consolidated cumulative quarter The Japanese economy during the first quarter of the current consolidated cumulative period, showed signs of a moderate recovery, supported by improvements in employment and income environments, as well as the effect of policies. However, the outlook remains uncertain due to continued inflation and the impact of rising consumer prices driven by yen depreciation. Healthcare industry in which the Group operates, various policies such as the 8th national medical plan, the 4th Phase Medical Cost Optimization Plan, and reforms in doctors' work styles has been launched. There is a continued demand to build an efficient and high-quality medical care system. In the Group business under such conditions, the business performance largely progressed as planned due to smooth progress of the projects in the Total Pack Produce business, etc.. Furthermore, this year is the final year of our Medium- term management plan "SHIP VISION 2024", the Group had kept on promoting 4 core strategic measures set forth in the plan, "Further high growth of core business", "Further expand value", "Functional organization enhancement strategy", and "Activities for sustainability". For the first quarter of the current consolidated cumulative period, the various factors noted above resulted in net sales of 155,219 million yen (up 6.0% YoY), operating profit of 3,502 million yen (down 8.8% YoY), ordinary profit of 4,485 million yen (down 3.5% YoY), and profit attributable to owners of the parent of 3,065 million yen (up 2.2% YoY). Business results by segment are summarized below. (i)    Total Pack Produce business In Total Pack Produce business, the projects were steadily progressed. However, contribution from the Myanmar business were not included from this fiscal year, and there was a reactionary decrease from concentration of deals with some manufacturers during the end of the previous FY, resulting in a decrease in profits compare with same period last year. As a result, this segment recorded net sales of 25,307 million yen (down 9.2% YoY) and segment profit (operating profit) of 1,098 million yen (down 17.2% YoY).
(ii)   Medical Supply business
In Medical Supply business, there were decreases in profits because sales of equipment decreased YoY whereas several new SPD cases started. As a result, this segment recorded net sales of 112,613 million yen (up 10.7% YoY) and segment profit (operating profit) of 963 million yen (down 22.7% YoY).
(iii) Lifecare business
In Lifecare business, in the nursing care business, the nursing care homes maintained high occupancy rate even after the review of administration fee. In the food provision service, strategic restructuring of the business allowed us to overcome the rise in food prices, leading to increased sales and profits. As a result, this segment recorded net sales of 9,135 million yen (up 2.4% YoY) and segment profit (operating profit) of 620 million yen (up 9.8% YoY).
(iv) Dispensing Pharmacy business
In Dispensing Pharmacy business, the performance remained firm due to the new store openings and improvement in management efficiency. As a result, this segment recorded net sales of 8,162 million yen (up 3.3% YoY) and segment profit (operating profit) of 793 million yen (up 7.6% YoY). for First Quarter of Fiscal Year Ending March 31, 2025 (2) Outlook Analysis of financial position of consolidated cumulative quarter Assets at the end of the consolidated first quarter stood at 377,014 million yen, down 9,805 million yen from the end of the previous consolidated fiscal year. The primary reasons for this decline included decreases of 18,313 million yen in "notes, accounts receivable, and contract asset", despite increases of 2,709 million yen in "merchandise and finished goods", 1,966 million yen in "cash and deposits", 1,594 million yen in "Work in process" 1,241 million yen in "investment securities". Liabilities stood at 236,651 million yen, down 7,952 million yen from the end of the previous consolidated fiscal year. The primary reasons for this decline included decreases of 7,324 million yen in "notes and accounts payable – trade", 3,373 million yen in "income taxes payable", despite increases of 4,124 million yen in "electronically recorded obligations – operating". Net assets stood at 140,363 million yen, down 1,852 million yen from the end of the previous consolidated fiscal year. The primary reasons for this increase included decrease of 4,717 million yen in "retained earnings" due to payment of dividends, despite increase of 3,065 million yen in "retained earnings" from profit attributable to owners of parent. As a result of all these factors, equity capital ratio at the end of the consolidated first quarter stood at 36.7% (up 0.6% from the end of the previous consolidated fiscal year) (3) Information on consolidated financial forecasts and other forward-looking statements In general, business performance matched financial forecasts made at the start of the period. The consolidated financial forecasts for the fiscal year remain unchanged from the forecasts announced on May 10, 2024.

2. Quarterly consolidated financial statements and notes thereto

for First Quarter of Fiscal Year Ending March 31, 2025
for First Quarter of Fiscal Year Ending March 31, 2025 (2) Quarterly consolidated statement of income and consolidated statement of comprehensive income Quarterly consolidated statement of income
for First Quarter of Fiscal Year Ending March 31, 2025 Quarterly consolidated statement of comprehensive income
(3) Notes on consolidated quarterly financial statements (Notes on changes of accounting policies) "Accounting Standard for Corporate, Inhabitant and Enterprise Taxes" (corporate accounting standards No. 27, October 28 th 2022 ) , "Accounting Standard for Presentation of Comprehensive Income" (corporate accounting standards No. 25, October 28th 2022) and "Guidance on Accounting Standard for Tax Effect Accounting" (guidance of corporate accounting standards No. 28, October 28th 2022) have been adopted from the start of the first quarter of the current consolidated cumulative period. There is no effect toward the Quarterly consolidated financial statements by the changes of these accounting policies. (Notes on Segment information, etc.) Previous consolidated cumulative first quarter (April 1 – June 30, 2023) I.
Net sales and profit (loss) by reportable segments l 1. The figure of (32) million yen in adjustments to segment profit includes (29) million yen for the cancellation of intersegment transactions and (5) million yen for companywide costs not allocated to each reportable segment. These companywide costs consist mainly of parent company operating expenses and sales, general, and administrative expenses not attributable to individual reportable segments. 2. Segment profit is adjusted against the operating profit reported on the Quarterly consolidated statement of income. 2 Information on impairment loss and goodwill on fixed assets by reportable segments No material impairment losses, changes in the amount of goodwill, and material gains on negative goodwill on fixed assets was recognized in the first quarter of the current consolidated fiscal year. Consolidated cumulative first quarter (April 1 – June 30, 2024) II
Net sales and profit (loss) by reportable segments l 1. The figure of 26 million yen in adjustments to segment profit includes (31) million yen for the cancellation of intersegment transactions and 48 million yen for companywide costs not allocated to an individual reportable segment. These companywide costs consist mainly of parent company operating expenses and sales, general, and administrative expenses not attributable to individual reportable segments. 2.Segment profit is adjusted against the operating profit reported on the Quarterly consolidated statement of income. 2 Information on impairment loss and goodwill on fixed assets by reportable segments No material impairment losses, changes in the amount of goodwill, and material gains on negative goodwill on fixed assets was recognized in the first quarter of the current consolidated fiscal year. (Notes in the event of significant changes in the amount of shareholders' equity) None (Notes on the going concern assumption) None
(Notes on statements of Cash Flows)
We don't have statements of Quarterly consolidated Cash Flows during consolidated cumulative quarter. Depreciation and amortization of the period (including depreciation expense of intangible assets and excluding goodwill) and amortization of goodwill are below:
(Changes in the scope of consolidation or of application of equity method) (Changes in the scope of consolidation) During the first quarter of this consolidated fiscal year, our consolidated subsidiary, SHIP HEALTHCARE PHARMACY EAST JAPAN, INC., absorbed and merged C.M.J, Ltd. and FRIENDS, Ltd., which were consolidated subsidiary companies of our group.